Opendata, web and dolomites

INFRAFRONTIER2020 SIGNED

Towards enduring mouse resources and services advancing research into human health and disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "INFRAFRONTIER2020" data sheet

The following table provides information about the project.

Coordinator
INFRAFRONTIER GMBH 

Organization address
address: INGOLSTADTER LANDSTRASSE 1
city: NEUHERBERG
postcode: 85764
website: www.infrafrontier.eu

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.infrafrontier.eu
 Total cost 4˙968˙252 €
 EC max contribution 4˙955˙877 € (100%)
 Programme 1. H2020-EU.1.4.1.1. (Developing new world-class research infrastructures)
 Code Call H2020-INFRADEV-2016-1
 Funding Scheme CSA
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2020-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INFRAFRONTIER GMBH DE (NEUHERBERG) coordinator 1˙837˙700.00
2    HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH DE (NEUHERBERG) participant 477˙872.00
3    CONSIGLIO NAZIONALE DELLE RICERCHE IT (ROMA) participant 384˙000.00
4    CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE FR (ILLKIRCH GRAFFENSTADEN) participant 306˙900.00
5    UNITED KINGDOM RESEARCH AND INNOVATION UK (SWINDON) participant 227˙905.00
6    BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING EL (VARI-ATHENS) participant 215˙600.00
7    EUROPEAN MOLECULAR BIOLOGY LABORATORY DE (HEIDELBERG) participant 212˙800.00
8    USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE CZ (PRAHA 4) participant 195˙528.00
9    OULUN YLIOPISTO FI (OULU) participant 140˙100.00
10    FUNDACAO CALOUSTE GULBENKIAN PT (LISBOA) participant 120˙539.00
11    STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS NL (AMSTERDAM) participant 114˙750.00
12    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 96˙460.00
13    BIOMEDCODE ELLAS ANONIMI ETERIA EPISTIMONIKIS KAI TEXNOLOGIKIS EREVNAS KAI EMBORIKIS EKMETALLEFSIS EPHARMOGON IATRIKIS EL (VARI) participant 91˙125.00
14    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 77˙321.00
15    AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS ES (MADRID) participant 72˙625.00
16    GENOME RESEARCH LIMITED UK (LONDON) participant 69˙875.00
17    CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS FR (PARIS) participant 69˙773.00
18    INSTITUT PASTEUR FR (PARIS CEDEX 15) participant 42˙600.00
19    THE UNIVERSITY OF SHEFFIELD UK (SHEFFIELD) participant 40˙800.00
20    TSE SYSTEMS GMBH DE (BAD HOMBURG VOR DER HOHE) participant 25˙600.00
21    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) participant 22˙400.00
22    ACADEMISCH ZIEKENHUIS GRONINGEN NL (GRONINGEN) participant 20˙800.00
23    AYOXXA BIOSYSTEMS GMBH DE (Cologne) participant 20˙800.00
24    MEDIZINISCHE HOCHSCHULE HANNOVER DE (HANNOVER) participant 17˙600.00
25    VETERINAERMEDIZINISCHE UNIVERSITAET WIEN AT (VIENNA) participant 16˙000.00
26    HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH DE (BRAUNSCHWEIG) participant 12˙800.00
27    TEL AVIV UNIVERSITY IL (TEL AVIV) participant 12˙800.00
28    UNIVERSIDAD AUTONOMA DE BARCELONA ES (CERDANYOLA DEL VALLES) participant 12˙800.00
29    MEDICAL RESEARCH COUNCIL UK (SWINDON) participant 0.00
30    Toronto Centre for Phenogenomics Inc. CA (Toronto) participant 0.00

Map

 Project objective

The INFRAFRONTIER RI integrates European Mouse Clinics and the European Mouse Mutant Archive with the common goal to ensure access to mouse models for basic research of human health and disease, and to translate this knowledge into therapeutic approaches for the benefit of the European society.

The expanded INFRAFRONTIER2020 network, coordinated by the INFRAFRONTIER GmbH, includes 3 SMEs and is strategically responding to the INFRADEV3 call with aligned objectives to advance the long-term sustainability which are 1) development of business models and a stable legal framework; 2) raise awareness of the INFRAFRONTIER RI; 3) provide bespoke services aligned with user demands; 4) promote best practices in mouse phenogenomics; 5) enhance robustness of the INFRAFRONTIER IT infrastructure and use of the EMMA strain resource; and 6) improve business processes. Towards achieving these objectives key INFRAFRONTIER2020 project deliverables are: • INFRAFRONTIER Business Plan2.0, and business models for all services • Stable legal framework built on the INFRAFRONTIER legal entity • INFRAFRONTIER annual stakeholder conferences • Customised mouse model and secondary phenotyping pilot services • INFRAFRONTIER advanced training schools in mouse phenogenomics • Reengineered EMMA Database2.0 system • Annotated mouse models of human diseases • Quality management system for the legal entity

INFRAFRONTIER2020 will 1) enhance the sustainable operation of the INFRAFRONTIER RI; 2) continue to structure the ERA, 3) foster innovation, and 4) address major societal challenges in human health by customised service pilots supporting research into common and rare diseases. A sustainable INFRAFRONTIER RI will ensure the quality of deposited mice and support the reproducibility of biological results. Outreach efforts will raise awareness of resources and services and facilitate sustainable engagement with industry and global consortia such as the International Mouse Phenotyping Consortium

 Deliverables

List of deliverables.
Data management plan Open Research Data Pilot 2020-02-24 17:20:03

Take a look to the deliverables list in detail:  detailed list of INFRAFRONTIER2020 deliverables.

 Publications

year authors and title journal last update
List of publications.
2018 Ana Luisa Cardoso, Adelaide Fernandes, Juan Antonio Aguilar-Pimentel, Martin Hrabě de Angelis, Joana Ribeiro Guedes, Maria Alexandra Brito, Saida Ortolano, Giovambattista Pani, Sophia Athanasopoulou, Efstathios S. Gonos, Markus Schosserer, Johannes Grillari, Pärt Peterson, Bilge Guvenc Tuna, Soner Dogan, Angelika Meyer, Ronald van Os, Anne-Ulrike Trendelenburg
Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases
published pages: 214-277, ISSN: 1568-1637, DOI: 10.1016/j.arr.2018.07.004
Ageing Research Reviews 47 2020-02-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INFRAFRONTIER2020" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INFRAFRONTIER2020" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.4.1.1.)

STREAMLINE (2019)

Sustainable research at micro and nano X-ray beamlines

Read More  

SHARE-COHESION (2019)

Cohesion in further developing and innovating SHARE across all 28 member countries

Read More  

IS_MIRRI21 (2020)

Implementation and Sustainability of Microbial Resource Research Infrastructure for 21st Century

Read More